Form 144 Cardlytics For: 2 July
- Investing.com
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cardlytics Inc (CDLX)
The Cardlytics share price today is 4.47, view NASDAQ CDLX stock exchange data. Track the latest Cardlytics share price with real-time updates on CDLX stock performance including market cap, day range, 52-week range and dividend yield. Access CDLX charts, earnings dates and analyst estimates to support your investment decisions.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.26
4.57
52 wk Range
4.26
32.80
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.264.57
52 wk Range
4.2632.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CDLX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
10.75
Upside
+140.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
- Cardlytics (CDLX) CEO Gupta sells $82,891 in shares
- Investing.com
- Cardlytics Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form 144 Cardlytics For: 6 April
- Investing.com
- Form 144 Cardlytics For: 2 July
- Investing.com
- Cardlytics Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Form DEF 14A Cardlytics Inc For: 14 April
- Investing.com
- Form 144 Cardlytics For: 7 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
3 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 10.75
(+140.49% Upside)
Cardlytics Inc Earnings Call Summary for Q1/2026
- Cardlytics Q1 2026 EPS of -$0.11 beat forecast of -$0.26 by 57.69%, driven by strong cost management and operational efficiency.
- Revenue of $34.3M missed estimates by 29.57%, down 39% YoY, primarily due to Bank of America client departure impacting growth.
- Adjusted EBITDA turned positive at $0.2M vs. -$4.1M in Q1 2025; free cash flow improved to -$7.9M from -$10.8M year-over-year.
- Q2 2026 guidance projects billings of $61M-$67M and revenue of $35M-$40M, targeting sequential growth and network expansion.
- Stock rose 2.5% to $0.82 in aftermarket trading despite trading near 52-week low of $0.66 with market cap of $42.96M.
Last Updated: 08-05-2026, 06:32 am
Read Full TranscriptEarnings
Latest Release
07-05-2026
EPS / Forecast
-0.80 / -2.60
Revenue / Forecast
34.32M / 48.7M
Compare CDLX to Peers and Sector
Metrics to compare | CDLX | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipCDLXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.2x | −2.1x | 7.0x | |
PEG Ratio | 0.00 | 0.05 | 0.01 | |
Price/Book | −6.5x | 2.3x | 1.8x | |
Price / LTM Sales | 0.1x | 2.2x | 1.3x | |
Upside (Analyst Target) | 123.7% | 7.6% | 32.3% | |
Fair Value Upside | Unlock | 1.1% | 17.8% | Unlock |
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. Cardlytics, Inc. was incorporated in 2008 and is headquartered in Atlanta, Georgia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Cardlytics (CDLX) Share Price Today?
The Cardlytics share price today is 4.47.
What is the current Cardlytics (CDLX) share price and day range?
As of 05-07-2026, the Cardlytics share price is 4.47, with a previous close of 4.44. The share price has ranged from 4.26 to 4.57 today, while the 52-week range spans from 4.26 to 32.80.
What Is the Cardlytics Market Cap?
As of today, Cardlytics market cap is 25.96M.
What Is the Cardlytics (CDLX) Share Price Target?
The average 12-month share price target for Cardlytics is 10.75, with a high estimate of 15 and a low estimate of 8. 0 analysts recommend buying, while 1 suggest selling, with an overall rating of Neutral and +140.49% Upside potential.
What Is Cardlytics's Earnings Per Share (TTM)?
The Cardlytics EPS (TTM) is -19.86.
When Is the Next Cardlytics Earnings Date?
Cardlytics will release its next earnings report on 04-08-2026.
From a Technical Analysis Perspective, Is CDLX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Cardlytics Trade On?
Cardlytics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Cardlytics?
The stock symbol for Cardlytics is "CDLX."
How Many Times Has Cardlytics Stock Split?
Cardlytics has split 1 times.
How Many Employees Does Cardlytics Have?
Cardlytics has 224 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.